Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting GD2 with antitumor activity, used to study neuroblastoma, osteosarcoma, and other GD2-positive cancers.
Purity:
100.00%
CAS Number:
[1879925-92-4]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted